James Graham: CEO of Recce Pharmaceuticals

Portrait of James Graham

James Graham, CEO of Recce Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Recce is working to develop a new class of synthetic anti-infectives designed to address the threat of antibiotic-resistant superbugs.

Historical image of Shionogi employee in the lab.
Shionogi

140 Years

Steinway Annual Report cover detail
Steinway Musical Instruments

Extending Our Reach

Alexion Patient portrait
Alexion Pharmaceuticals

Patient Videos